LOC105379185: A Protein of Interest as a Potential Drug Target or Biomarker

LOC105379185: A Protein of Interest as a Potential Drug Target or Biomarker

LOC105379185 (LOC105379185 variant X2) is a protein that is expressed in various tissues of the human body, including the brain, heart, kidneys, and liver. It is a member of the G protein-coupled receptor gene family , which is a large family of transmembrane proteins that play an important role in cellular signaling.

LOC105379185 is a variant of the X2 gene, which is located on chromosome 10q24. X2 variants are a common type of genetic variation that occur in the gene region that encodes the X chromosome. These variants are often associated with a range of neurological and developmental disorders , including mental retardation, developmental delays, and chronic pain.

The LOC105379185 protein is of particular interest as a potential drug target or biomarker because of its involvement in a number of cellular signaling pathways that are involved in a wide range of physiological processes. One of its most well-studied functions is its role in the regulation of pain perception and neuroinflammation.

LOC105379185 is involved in the production of a variety of signaling molecules that are involved in pain perception and neuroinflammation. For example, it has been shown to play a role in the production of inflammatory cytokines, such as TNF-alpha and IL-1beta, which are involved in the recruitment of immune cells to the site of pain and injury. It is also involved in the production of neurotransmitters, such as dopamine and GABA, which are involved in the regulation of pain perception and mood.

In addition to its role in pain perception and neuroinflammation, LOC105379185 is also involved in a number of other cellular signaling pathways that are important for maintaining normal physiological function. For example, it is involved in the regulation of cell survival and proliferation, as well as the regulation of cell-cell adhesion and migration.

Given its involvement in a wide range of cellular signaling pathways, LOC105379185 is a promising target for drug development. Researchers have identified several potential drug compounds that are able to interact with the LOC105379185 protein and have shown that these compounds can inhibit its activity. These compounds are currently being tested in a variety of animal models of pain and neuroinflammation to determine their effectiveness as potential therapeutic compounds.

In addition to its potential as a drug target, LOC105379185 is also a promising biomarker for a variety of neurological and psychiatric disorders. For example, research has shown that LOC105379185 is often reduced in individuals with schizophrenic-related disorders, and that these individuals may have increased levels of other proteins that are involved in the development of these disorders. Similarly, LOC105379185 has been shown to be reduced in individuals with major depressive disorder, and that these individuals may have increased levels of other proteins that are involved in the development of this disorder.

Overall, LOC105379185 is a protein that is of great interest as a potential drug target or biomarker due to its involvement in a wide range of cellular signaling pathways that are important for maintaining normal physiological function. Further research is needed to fully understand the role of LOC105379185 in pain perception and neuroinflammation, as well as its potential as a therapeutic compound.

Protein Name: Uncharacterized LOC105379185, Transcript Variant X2

The "LOC105379185 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LOC105379185 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

LOC105379193 | LOC105379232 | LOC105379235 | LOC105379242 | LOC105379243 | LOC105379289 | LOC105379297 | LOC105379314 | LOC105379315 | LOC105379318 | LOC105379341 | LOC105379344 | LOC105379362 | LOC105379365 | LOC105379382 | LOC105379385 | LOC105379395 | LOC105379399 | LOC105379490 | LOC105379514 | LOC105379570 | LOC105379599 | LOC105379614 | LOC105379647 | LOC105379648 | LOC105379652 | LOC105379656 | LOC105379658 | LOC105379660 | LOC105379663 | LOC105379664 | LOC105379665 | LOC105379667 | LOC105379749 | LOC105379857 | LOC105447645 | LOC107983962 | LOC107983963 | LOC107983974 | LOC107983976 | LOC107983981 | LOC107983982 | LOC107983986 | LOC107984003 | LOC107984041 | LOC107984063 | LOC107984079 | LOC107984098 | LOC107984108 | LOC107984113 | LOC107984118 | LOC107984129 | LOC107984137 | LOC107984144 | LOC107984145 | LOC107984146 | LOC107984179 | LOC107984214 | LOC107984221 | LOC107984238 | LOC107984251 | LOC107984256 | LOC107984264 | LOC107984284 | LOC107984314 | LOC107984316 | LOC107984326 | LOC107984361 | LOC107984363 | LOC107984381 | LOC107984390 | LOC107984408 | LOC107984526 | LOC107984530 | LOC107984536 | LOC107984543 | LOC107984558 | LOC107984563 | LOC107984567 | LOC107984576 | LOC107984588 | LOC107984625 | LOC107984626 | LOC107984634 | LOC107984647 | LOC107984654 | LOC107984665 | LOC107984671 | LOC107984703 | LOC107984706 | LOC107984710 | LOC107984737 | LOC107984755 | LOC107984782 | LOC107984788 | LOC107984793 | LOC107984798 | LOC107984827 | LOC107984867 | LOC107984869